Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: A review of available literature

Neurocritical Care

Volumn 15, Issue 3, 2011, Pages 609-622

  Larach, Daniel B ^b   Kofke, W Andrew ^a   Le Roux, Peter ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain tissue oxygen; Cerebral metabolism; Cerebral microdialysis; Lactate pyruvate ratio; Microdialysis; Monitoring; Multimodality monitoring; Neurochemical monitoring; Subarachnoid hemorrhage; Traumatic brain injury

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ALCOHOL; CATECHOLAMINE DERIVATIVE; DIAZEPAM; ESMOLOL; ETOMIDATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCEROL; GLYCERYL TRINITRATE; HALOTHANE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENALINE; LACTATE DEHYDROGENASE; LACTIC ACID; LORAZEPAM; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITROPRUSSIDE SODIUM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RITODRINE; VASOPRESSIN;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL DAMAGE; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY CONSUMPTION; ENERGY METABOLISM; EXTRACELLULAR SPACE; GLYCOLYSIS; HUMAN; HYPERAMMONEMIA; HYPERCAPNIA; HYPOGLYCEMIA; HYPOTHYROIDISM; INTERSTITIAL FLUID; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SEIZURE; SEPSIS; TISSUE OXYGENATION;

AEROBIOSIS; ANAEROBIOSIS; BLOOD GLUCOSE; BRAIN; BRAIN INJURIES; CRITICAL CARE; ENERGY METABOLISM; EXTRACELLULAR FLUID; GLUTAMIC ACID; GLYCEROL; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; LACTIC ACID; MICRODIALYSIS; MONITORING, PHYSIOLOGIC; OXIDATION-REDUCTION; OXYGEN; PYRUVIC ACID; REGIONAL BLOOD FLOW;

EID: 84856259120     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9517-8     Document Type: Review

References (140)

1. Ungerstedt U, Pycock C. Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss. 1974;30: 44-55.
2. Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Curr Protoc Neurosci. 2009;47:7. 1.1-1.28.
3. Torregrossa MM, Kalivas PW. Microdialysis and the neurochemistry of addiction. Pharmacol Biochem Behav. 2008;90: 261-72. (Pubitemid 351787343)
4. Meeusen R. Exercise and the brain: insight in new therapeutic modalities. Ann Transplant. 2005;10:49-51.
5. van der Zeyden M, Oldenziel WH, Rea K, Cremers TI, Westerink BH. Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. Pharmacol Biochem Behav. 2008;90:135-47. (Pubitemid 351787344)
6. Li Y, Peris J, Zhong L, Derendorf H. Microdialysis as a tool in local pharmacodynamics. AAPS J. 2006;8:E222-35.
7. Stiller CO, Taylor BK, Linderoth B, Gustafsson H, Warsame Afrah A, Brodin E. Microdialysis in pain research. Adv Drug Deliv Rev. 2003;55:1065-79. (Pubitemid 37288988)
8. Meyerson BA, Linderoth B, Karlsson H, Ungerstedt U. Extracellular measurements in the thalamus of parkinsonian patients. Life Sci. 1990;46:301-8.
9. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma. 2005; 22:3-41.
10. Bellander BM, Cantais E, Enblad P, et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med. 2004; 30:2166-9. (Pubitemid 40174251)
11. Belli A, Sen J, Petzold A, Russo S, Kitchen N, Smith M. Metabolic failure precedes intracranial pressure rises in traumatic brain injury: a microdialysis study. Acta Neurochir (Wien). 2008;150:461-9.
12. Adamides AA, Rosenfeldt FL, Winter CD, et al. Brain tissue lactate elevations predict episodes of intracranial hypertension in patients with traumatic brain injury. J Am Coll Surg. 2009; 209:531-9.
13. Ungerstedt U, Rostami E. Microdialysis in neurointensive care. Curr Pharm Des. 2004;10:2145-52. (Pubitemid 38832756)
14. Goodman JC, Robertson CS. Microdialysis: is it ready for prime time? Curr Opin Crit Care. 2009;15:110-7.
15. Nordström CH. Cerebral energy metabolism and microdialysis in neurocritical care. Childs Nerv Syst. 2010;26:465-72.
16. Tisdall MM, Smith M. Cerebral microdialysis: research technique or clinical tool. Br J Anaesth. 2006;97:18-25.
17. Oddo M, Schmidt JM, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008;36: 3233-8.
18. Vespa PM, McArthur D, O'Phelan K, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab. 2003; 23:865-77. (Pubitemid 36818694)
19. Oddo M, Milby A, Chen I, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:1275-81.
20. Nordström CH, Reinstrup P, Xu W, Gärdenfors A, Ungerstedt U. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism. Anesthesiology. 2003;98:809-14. (Pubitemid 36373212)
21. Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35:2830-6. (Pubitemid 350175782)
22. Hashemi P, Bhatia R, Nakamura H, et al. Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for risk of an adverse effect of Leão's spreading depression. J Cereb Blood Flow Metab. 2009; 29:166-75.
23. Schneweis S, Grond M, Staub F, et al. Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke. 2001;32:1863-7.
24. Nortje J, Coles JP, Timofeev I, et al. Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Crit Care Med. 2008;36: 273-81.
25. Marcoux J, McArthur DA, Miller C, et al. Persistent metabolic crisis as measured by elevated cerebral microdialysis lactatepyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med. 2008;36:2871-7.
26. Hillered L, Persson L, Nilsson P, Ronne-Engstrom E, Enblad P. Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis. Curr Opin Crit Care. 2006;12:112-8.
27. Leegsma-Vogt G, van der Werf S, Venema K, Korf J. Modeling cerebral arteriovenous lactate kinetics after intravenous lactate infusion in the rat. J Cereb Blood Flow Metab. 2004;24: 1071-80. (Pubitemid 39332146)
28. Miller LP, Oldendorf WH. Regional kinetic constants for bloodbrain barrier pyruvic acid transport in conscious rats by the monocarboxylic acid carrier. J Neurochem. 1986;46:1412-6. (Pubitemid 16062540)
29. Hutchinson PJ, O'Connell MT, Al-Rawi PG, et al. Clinical cerebral microdialysis: a methodological study. J Neurosurg. 2000;93:37-43. (Pubitemid 30457321)
30. Nelson DL, Cox MM. Lehninger principles of biochemistry. 5th ed. New York: WH Freeman; 2008.
31. Johnston AJ, Gupta AK. Advanced monitoring in the neurology intensive care unit: microdialysis. Curr Opin Crit Care. 2002;8: 121-7.
32. Reinstrup P, Ståhl N, Mellergård P, Uski T, Ungerstedt U, Nordström CH. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery. 2000;47:701-9.
33. Gårdenfors A, Nilsson F, Skagerberg G, Ungerstedt U, Nordstro ̈m CH. Cerebral physiological and biochemical changes during vasogenic brain edema induced by intrathecal injection of bacterial lipopolysaccharides in piglets. Acta Neurochir. 2002;144:601-8.
34. Dusick JR, Glenn TC, Lee WN, et al. Increased pentose phosphate pathway flux after clinical traumatic brain injury: a [1, 2-13C2]glucose labeling study in humans. J Cereb Blood Flow Metab. 2007;27:1593-602. (Pubitemid 47301444)
35. Vespa P, Bergsneider M, Hattori N, et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab. 2005;25:763-4.
36. Simpson NE, Han Z, Berendzen KM, et al. Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: effects of pyruvate dehydrogenase complex deficiency and dichloroacetate. Mol Genet Metab. 2006;89:97-105. (Pubitemid 44205473)
37. Nakasaki H, Ohta M, Soeda J, et al. Clinical and biochemical aspects of thiamine treatment for metabolic acidosis during total parenteral nutrition. Nutrition. 1997;13:110-7. (Pubitemid 27172285)
38. Tinsa F, Ben Amor S, Kaabachi N, Ben Lasouad M, Boussetta K, Bousnina S. Unusual case of thiamine responsive megaloblastic anemia. Tunis Med. 2009;87:159-63.
39. Poggi-Travert F, Martin D, Billette de Villemeur T, et al. Metabolic intermediates in lactic acidosis: compounds, samples and interpretation. J Inherit Metab Dis. 1996;19:478-88. (Pubitemid 26302524)
40. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. NEJM. 1992;327:1564-9.
41. Hoppel CL, Kerr DS, Dahms B, Roessmann U. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal- cardiac myopathy and encephalopathy. J Clin Invest. 1987; 80:71-7. (Pubitemid 17097518)
42. Moreadith RW, Batshaw ML, Ohnishi T, et al. Deficiency of the iron-sulfur clusters ofmitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis. J Clin Invest. 1984;74:685-97. (Pubitemid 14031003)
43. Robinson BH, McKay N, Goodyer P, Lancaster G. Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacitcacidemia. Am J Hum Genet. 1985;37:938-46. (Pubitemid 16224134)
44. Van Hove JL, Saenz MS, Thomas JA, et al. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res. 2010;68:159-64.
45. Chesney RW, Kaplan BS, Colle E, et al. Abnormalities of carbohydrate metabolism in idiopathic Fanconi syndrome. Pediatr Res. 1980;14:209-15. (Pubitemid 10133514)
46. Boustany RN, Aprille JR, Halperin J, Levy H, DeLong GR. Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol. 1983;14:462-70. (Pubitemid 13010047)
47. Komaki H, Nishigaki Y, Fuku N, et al. Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency. Biochim Biophys Acta. 2010;1800:313-5.
48. Mannan AA, Sharma MC, Shrivastava P, et al. Leigh's syndrome. Indian J Pediatr. 2004;71:1029-33. (Pubitemid 40029845)
49. Hertz L, Kala G. Energy metabolism in brain cells: effects of elevated ammonia concentrations. Metab Brain Dis. 2007;22: 199-218. (Pubitemid 47624320)
50. Lin S, Raabe W. Ammonia intoxication: effects on cerebral cortex and spinal cord. J Neurochem. 1985;44:1252-8. (Pubitemid 15107066)
51. Adams JM, Feustel PJ, Donnelly DF, Dutton RE. Hypoxia, hyperammonemia, and cerebrospinal fluid metabolites. Adv Shock Res. 1978;1:209-20.
52. O'Connor JE, Costell M, Grisolía S. Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain. Neurochem Res. 1984;9:563-70. (Pubitemid 14120961)
53. Hindfelt B, Plum F, Duffy TE. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest. 1977;59:386-96. (Pubitemid 8061207)
54. Bjerring PN, Hauerberg J, Frederiksen HJ, et al. Cerebral glutamine concentration and lactate-pyruvate ratio in patients with acute liver failure. Neurocrit Care. 2008;9:3-7.
55. Ratnakumari L, Murthy CR. Response of rat cerebral glycolytic enzymes to hyperammonemic states. Neurosci Lett. 1993;161: 37-40. (Pubitemid 23311059)
56. Qureshi K, Rama Rao KV, Qureshi IA. Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-Lcarnitine. Neurochem Res. 1998;23:855-61. (Pubitemid 28178158)
57. Ratnakumari L, Qureshi IA, Butterworth RF. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem Biophys Res Commun. 1992;184:746-51.
58. She P, Zhou Y, Zhang Z, Griffin K, Gowda K, Lynch CJ. Disruption of BCAA metabolism in mice impairs exercise metabolism and endurance. J Appl Physiol. 2010;108:941-9.
59. Kauppinen RA, Sihra TS, Nicholls DG. Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates. Biochim Biophys Acta. 1987;930:173-8.
60. Nagasaka H, Okano Y, Tsukahara H, et al. Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period. Mol Genet Metab. 2009;97:21-6.
61. Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002;544:687-93. (Pubitemid 35355950)
62. Michenfelder JD, Theye RA. In vivo toxic effects of halothane on canine cerebral metabolic pathways. Am J Physiol. 1975;229: 1050-5.
63. Dahlbacka S, Mäkelä J, Kaakinen T, et al. Propofol is associated with impaired brain metabolism during hypothermic circulatory arrest: an experimental microdialysis study. Heart Surg Forum. 2006;9:E710-8.
64. Carles M, Dellamonica J, Roux J, et al. Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia-reperfusion. Br J Anaesth. 2008;100:29-35. (Pubitemid 351773419)
65. Marian M, Parrino C, Leo AM, Vincenti E, Bindoli A, Scutari G. Effect of the intravenous anesthetic 2,6-diisopropylphenol on respiration and energy production by rat brain synaptosomes. Neurochem Res. 1997;22:287-92. (Pubitemid 27091817)
66. Branca D, Roberti MS, Lorenzin P, Vincenti E, Scutari G. Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochem Pharmacol. 1991;42:87-90.
67. Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 2009;75:339-44.
68. Pisapia JM, Wendell LC, Kumar MA, Zager EL, Levine JM. Lactate-to-pyruvate ratio as a marker of propofol infusion syndrome after subarachnoid hemorrhage. Neurocrit Care. 2010. doi:10.1007/s12028-010-9467-6.
69. Nam YT, Kim JS, Park KW. Effects of hypotensive anesthesia with sodium nitroprusside or isoflurane on hemodynamic and metabolic changes. Yonsei Med J. 1992;33:320-5.
70. Michenfelder JD. Cyanide release from sodium nitroprusside in the dog. Anesthesiology. 1977;46:196-201. (Pubitemid 8049365)
71. Tinker JH, Michenfelder JD. Cardiac cyanide toxicity induced by nitroprusside in the dog: potential for reversal. Anesthesiology. 1978;49:109-16. (Pubitemid 9013598)
72. Dai YL, Luk TH, Siu CW, et al. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease. Cardiovasc Toxicol. 2010;10:130-8.
73. Ruddick JA. Toxicology, metabolism, and biochemistry of 1,2- propanediol. Toxicol Appl Pharmacol. 1972;21:102-11.
74. Saini M, Nagpaul JP, Amma MK. Effect of propane-1,2-diol ingestion on carbohydrate metabolism in female rat erythrocytes. J Appl Toxicol. 1993;13:69-75. (Pubitemid 23032665)
75. Morshed KM, Nagpaul JP, Majumdar S, Amma MKP. Kinetics of oral propylene glycol-induced acute hyperlactatemia. Biochem Med Metab Biol. 1989;42:87-94. (Pubitemid 19259592)
76. Schölmerich J, Kitamura S, Miyai K. Effects of propylene glycol on redox state of the perfused rat liver - a note of caution. Res Exp Med (Berl). 1989;189:39-42. (Pubitemid 19064018)
77. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines. Chest. 2005;128:1674-81.
78. Barnes BJ, Gerst C, Smith JR, Terrell AR, Mullins ME. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy. 2006;26:23-33. (Pubitemid 43082924)
79. Ganesh A, Audu P. Hyperosmolar, increased-anion-gap metabolic acidosis and hyperglycemia after etomidate infusion. J Clin Anesth. 2008;20:290-3. (Pubitemid 351915826)
80. Szajewski J. Poisons information monographs: Propylene glycol. No. 443. Geneva, Switzerland: International Programme on Chemical Safety, 1994.
81. Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Sem Dial. 2007;20: 217-9.
82. Rengel-Aranda M, Gougoux A, Vinay P, Lopez-Novoa JM. Effect of valproate on renal metabolism in the intact dog. Kidney Int. 1988;34:645-54.
83. Dubas TC, Johnson WJ. Metformin-induced lactic acidosis: potentiation by ethanol. Res Commun Chem Pathol Pharmacol. 1981;33:21-31. (Pubitemid 11010336)
84. Jalling O, Olsen C. The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell. Acta Pharmacol Toxicol (Copenh). 1984;54:327-32. (Pubitemid 14100955)
85. Nattrass M, Hinks L, Smythe P, Todd PG, Alberti KGMM. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetes. Horm Metab Res. 1979;11: 332-7. (Pubitemid 9212064)
86. Ramanathan S, Masih AK, Ashok U, Arismendy J, Turndorf H. Concentrations of lactate and pyruvate in maternal and neonatal blood with different intravenous fluids used for prehydration before epidural anesthesia. Anesth Analg. 1984;63:69-74. (Pubitemid 14216415)
87. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia. 2007;55:1251-62. (Pubitemid 47235366)
88. Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia. 2007;55:1263-71. (Pubitemid 47235367)
89. Bittar PG, Charnay Y, Pellerin L, Bouras C, Magistretti PJ. Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab. 1996;16:1079-89. (Pubitemid 26365358)
90. Abi-Saab WM, Maggs DG, Jones T, et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab. 2002;22:271-9. (Pubitemid 34203054)
91. Agardh CD, Folbergrová J, Siesjö BK. Cerebral metabolic changes in profound, insulin-induced hypoglycemia, and in the recovery period following glucose administration. J Neurochem. 1978;31:1135-42. (Pubitemid 9039031)
92. Cardell M, Siesjö BK, Wieloch T. Changes in pyruvate dehydrogenase complex activity during and following severe insulininduced hypoglycemia. J Cereb Blood Flow Metab. 1991;11: 122-8.
93. Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS. Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med. 2008;34:1200-7. (Pubitemid 351904294)
94. Vespa P, Boonyaputthikul R, McArthur DL, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med. 2006;34:850-6.
95. Kennan RP, Takahashi K, Pan C, Shamoon H, Pan JW. Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia. J Cereb Blood Flow Metab. 2005;25:527-34.
96. Choi IY, Lee SP, Kim SG, Gruetter R. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J Cereb Blood Flow Metab. 2001;21:653-63. (Pubitemid 32510453)
97. Eckert B, Ryding E, Agardh CD. Sustained elevation of cerebral blood flow after hypoglycaemia in normal man. Diabetes Res Clin Pract. 1998;40:91-100. (Pubitemid 28308399)
98. Rosdahl H, Samuelsson AC, Ungerstedt U, Henriksson J. Influence of adrenergic agonists on the release of amino acids from rat skeletal muscle studied by microdialysis. Acta Physiol Scand. 1998;163:349-60. (Pubitemid 28375767)
99. Levy B, Mansart A, Bollaert PE, Franck P, Mallie JP. Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med. 2003;29:292-300. (Pubitemid 36384420)
100. Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997;23:282-7. (Pubitemid 27129993)
101. Pernet A, Walker M, Gill GV, Ørskov H, Alberti KGMM, Johnston DG. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin. Diabete Metab. 1984;10: 98-105. (Pubitemid 14079761)
102. Christensen NJ, Alberti KG, Brandsborg O. Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur J Clin Invest. 1975;5:415-23.
103. Heringlake M, Wernerus M, Grünefeld J, et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care. 2007;11:R51.
104. Cano A, Martínez P, Parrilla JJ, Abad L. Effects of intravenous ritodrine on lactate and pyruvate levels: role of glycemia and anaerobiosis. Obstet Gynecol. 1985;66:207-10. (Pubitemid 15049723)
105. d'Avila JC, Santiago AP, Amâncio RT, et al. Sepsis induces brain mitochondrial dysfunction. Crit Care Med. 2008;36: 1925-32.
106. Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol. 1986;250:E634-40.
107. Malaisse WJ, Nadi AB, Ladriere L, Zhang TM. Protective effects of succinic acid dimethyl ester infusion in experimental endotoxemia. Nutrition. 1997;13:330-41.
108. Gnaegi A, Feihl F, Boulat O, Waeber B, Liaudet L. Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia. Intensive Care Med. 2009;35: 1297-304.
109. Chvojka J, Sykora R, Krouzecky A, et al. Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care. 2008;12: R164.
110. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med. 1994;22:640-50. (Pubitemid 24121566)
111. Astiz M, Rackow EC, Weil MH, Schumer W. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock. 1988;26:311-20. (Pubitemid 18268355)
112. Blennow G, Folbergrová J, Nilsson B, Siesjö BK. Cerebral metabolic and circulatory changes in the rat during sustained seizures induced by DL-homocysteine. Brain Res. 1979;179: 129-46. (Pubitemid 10217476)
113. Folbergrová J, Jesina P, Drahota Z, et al. Mitochondrial complex I inhibition in cerebral cortex of immature rats following homocysteic acid-induced seizures. Exp Neurol. 2007;204:597-609. (Pubitemid 46497046)
114. Howse DCN. Metabolic responses to status epilepticus in the rat, cat, and mouse. Can J Physiol Pharmacol. 1979;57:205-12. (Pubitemid 9116979)
115. Folbergrová J, Ingvar M, Nevander G, Siesjö BK. Cerebral metabolic changes during and following fluorothyl-induced seizures in ventilated rats. J Neurochem. 1985;44:1419-26. (Pubitemid 15056909)
116. Ingvar M, Folbergrová J, Siesjö BK. Metabolic alterations underlying the development of hypermetabolic necrosis in the substantia nigra in status epilepticus. J Cereb Blood Flow Metab. 1987;7:103-8. (Pubitemid 17018322)
117. Chapman AG, Meldrum BS, Siesjö BK. Cerebral metabolic changes during prolonged epileptic seizures in rats. J Neurochem. 1977;28:1025-35. (Pubitemid 8098870)
118. Johansson BB, Fredriksson K. Cerebral energy metabolism during bicuculline-induced status epilepticus in spontaneously hypertensive rats. Acta Phys Scand. 1985;123:299-302. (Pubitemid 15033593)
119. Slais K, Vorisek I, Zoremba N, Homola A, Dmytrenko L, Sykova E. Brain metabolism and diffusion in the rat cerebral cortex during pilocarpine-induced status epilepticus. Exp Neurol. 2008;209:145-54.
120. Darbin O, Risso JJ, Carre E, Lonjon M, Naritoku DK. Metabolic changes in rat striatum following convulsive seizures. Brain Res. 2005;1050:124-9. (Pubitemid 40922725)
121. Claassen J, Jetté N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1256-65.
122. Folbergrová J, MacMillan V, Siesjö BK. The effect of moderate and marked hypercapnia upon the energy state and upon the cytoplasmic NADH-NAD+ ratio of the rat brain. J Neurochem. 1972;19:2497-505.
123. Folbergrová J, Pontén U, Siesjö BK. Patterns of changes in brain carbohydrate metabolites, amino acids and organic phosphates at increased carbon dioxide tensions. J Neurochem. 1974;22: 1115-25.
124. Weyne J, Demeester G, Leusen I. Effects of carbon dioxide, bicarbonate, and pH on lactate and pyruvate in the brain of rats. Pflugers Arch. 1970;31:292-311.
125. Kjällquist A ̊ , Nardini M, Siesjö BK. The regulation of extra- and intracellular acid-base parameters in the rat brain during hyperand hypocapnia. Acta Physiol Scand. 1969;76:485-94.
126. Granholm L, Siesjö BK. The effects of hypercapnia and hypocapnia upon the cerebrospinal fluid lactate and pyruvate concentrations and upon the lactate, pyruvate, ATP, ADP, phosphocreatine and creatine concentrations of cat brain tissue. Acta Physiol Scand. 1969;75:257-66.
127. Frauendorf E, Hartmann N, Hübner G, Meng W, Weber A. Das verhalten des laktat/pyruvat-quotienten im rahmen moderner schilddrüsendiagnostik. Z Gesamte Inn Med. 1980;35:155-61. (Pubitemid 10101249)
128. Hübner G, Schwinger E, Meng W. Zum verhalten von laktat und pyruvat sowie des laktat/pyruvat-quotienten im blut bei schilddru ̈ senfunktionsstörungen des menschen. Z Gesamte Inn Med. 1975;30:786-9.
129. Katyare SS, Joshi MV, Fatterpaker P, Sreenivasan A. Effect of thyroid deficiency on oxidative phosphorylation in rat liver, kidney, and brain mitochondria. Arch Biochem Biophys. 1977; 182:155-63. (Pubitemid 8130587)
130. Lecky FE, Little RA, Maycock PF, et al. Effect of alcohol on the lactate/pyruvate ratio of recently injured adults. Crit Care Med. 2002;30:981-5. (Pubitemid 34508017)
131. Yap M, Mascord DJ, Starmer GA, Whitfield JB. Studies on the chronopharmacology of ethanol. Alcohol Alcohol. 1993;28: 17-24. (Pubitemid 23107706)
132. Myrsten AL, Rydberg U, Ideström CM, Lamble R. Alcohol intoxication and hangover: modification of hangover by chlormethiazole. Psychopharmacology (Berl). 1980;69:117-25. (Pubitemid 10069531)
133. Ginestal da Cruz A, Correia JP, Menezes L. Ethanol metabolism in liver cirrhosis and chronic alcoholism. Acta Hepatogastroenterol (Stuttg). 1975;22:369-74.
134. Frayn KN, Coppack SW, Walsh PE, Butterworth HC, Humphreys SM, Pedrosa HC. Metabolic responses of forearm and adipose tissues to acute ethanol ingestion. Metabolism. 1990;39: 958-66. (Pubitemid 20293944)
135. Hollstedt C, Rydberg U, Olsson O, Buijten J. Effects of ethanol on the developing rat. I. Ethanol metabolism and effects on lactate, pyruvate, and glucose concentrations. Med Biol. 1980; 58:158-63. (Pubitemid 11161878)
136. Pronko PS, Velichko MG, Moroz AR, Rubanovich NN. Lowmolecular- weight metabolites relevant to ethanol metabolism: correlation with alcohol withdrawal severity and utility for identification of alcoholics. Alcohol Alcohol. 1997;32:761-8. (Pubitemid 28006016)
137. Krebs HA, Freedland RA, Hems R, Stubbs M. Inhibition of hepatic gluconeogenesis by ethanol. Biochem J. 1969;112: 117-24.
138. Tskuamoto S, Kanegae T, Saito M, et al. Concentrations of blood and urine ethanol, acetaldehyde, acetate and acetone during experimental hangover in volunteers. Arukoru Kenkyuto Yakubutsu Ison. 1991;26:500-10.
139. Martin E, Rosenthal RE, Fiskum G. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res. 2005;79:240-7. (Pubitemid 40116441)
140. Ehrig K, Heckel R, Lajios G. Molecular analysis of metabolic pathway with graph transformation. Lect Notes Comput Sci. 2006;4178:107-21. (Pubitemid 44608932)